Yaling Dou

407 total citations
35 papers, 277 citations indexed

About

Yaling Dou is a scholar working on Molecular Biology, Epidemiology and Hematology. According to data from OpenAlex, Yaling Dou has authored 35 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Epidemiology and 7 papers in Hematology. Recurrent topics in Yaling Dou's work include Cytomegalovirus and herpesvirus research (5 papers), Blood groups and transfusion (4 papers) and Molecular Biology Techniques and Applications (3 papers). Yaling Dou is often cited by papers focused on Cytomegalovirus and herpesvirus research (5 papers), Blood groups and transfusion (4 papers) and Molecular Biology Techniques and Applications (3 papers). Yaling Dou collaborates with scholars based in China, United Kingdom and Hong Kong. Yaling Dou's co-authors include Lingjun Kong, Jie Yi, Wenjing Liu, Hui Zhang, Zhuo Yang, Yu Chen, Jinhua Wang, Ran Gao, Guanhua Du and Wengong Wang and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Clinica Chimica Acta.

In The Last Decade

Yaling Dou

30 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaling Dou China 10 139 100 51 41 35 35 277
Keshav Raj Sigdel Nepal 8 140 1.0× 114 1.1× 45 0.9× 26 0.6× 79 2.3× 19 279
Weijian Zhu China 8 193 1.4× 127 1.3× 36 0.7× 29 0.7× 19 0.5× 23 258
Zenas Chang United States 7 124 0.9× 71 0.7× 12 0.2× 32 0.8× 48 1.4× 10 249
Huiqiang Liu China 11 108 0.8× 67 0.7× 72 1.4× 24 0.6× 64 1.8× 31 285
Yu-Li Chang Taiwan 7 170 1.2× 135 1.4× 60 1.2× 33 0.8× 16 0.5× 14 277
Ida Russo Italy 10 148 1.1× 96 1.0× 16 0.3× 44 1.1× 24 0.7× 22 280
Allison Hanlon United States 9 108 0.8× 29 0.3× 74 1.5× 71 1.7× 54 1.5× 19 234
Seema Sen India 11 112 0.8× 32 0.3× 65 1.3× 66 1.6× 36 1.0× 31 298

Countries citing papers authored by Yaling Dou

Since Specialization
Citations

This map shows the geographic impact of Yaling Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaling Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaling Dou more than expected).

Fields of papers citing papers by Yaling Dou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaling Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaling Dou. The network helps show where Yaling Dou may publish in the future.

Co-authorship network of co-authors of Yaling Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Yaling Dou. A scholar is included among the top collaborators of Yaling Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaling Dou. Yaling Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaoyan, Na Xu, Hui Tan, Yaling Dou, & Xiuli Wang. (2025). A novel {FeII[P4MoV6]2}-based complex for highly efficient and scalable selective oxidation of methyl phenyl sulfide to sulfoxide. Journal of Molecular Structure. 1347. 143283–143283. 3 indexed citations
2.
Zhang, Han, Ziran Wang, Zhuo Yang, et al.. (2025). Analysis of genotypic distribution and rare variants of patients with α/β-thalassemia screened in one hospital in Beijing, China. Human Genomics. 19(1). 13–13. 1 indexed citations
3.
Liu, Jinjie, et al.. (2025). Novel polycyclic meroterpenoids with protein tyrosine phosphatase 1B inhibitory activity isolated from desert-derived fungi Talaromyces sp. HMT-8. Natural Products and Bioprospecting. 15(1). 46–46. 1 indexed citations
5.
Wang, Ziran, Lingjun Kong, Rui Zhang, et al.. (2024). Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 11. 131–143. 3 indexed citations
7.
Yi, Jie, Jingjing Song, Lijun Du, et al.. (2023). Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR. Annals of Clinical Microbiology and Antimicrobials. 22(1). 102–102. 4 indexed citations
8.
Wang, Ziran, et al.. (2023). Prevalence of Ureaplasma species among patients at a tertiary hospital in China: a 10-year retrospective study from 2013 to 2022. European Journal of Clinical Microbiology & Infectious Diseases. 42(12). 1425–1437. 3 indexed citations
9.
Wang, Ziran, Jingjing Song, Lingjun Kong, et al.. (2023). Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension. Diabetes Metabolic Syndrome and Obesity. Volume 16. 1133–1147. 1 indexed citations
11.
Xu, Ying, Xiaozhou Wang, Jiao Zheng, et al.. (2022). Copy number assessment of SMN1 based on real-time PCR with high-resolution melting: fast and highly reliable testing. Brain and Development. 44(7). 462–468.
12.
Yi, Jie, et al.. (2021). Prevalence and Genotype Distribution of Human Papillomavirus Among Healthy Females in Beijing, China, 2016–2019. Infection and Drug Resistance. Volume 14. 4173–4182. 14 indexed citations
13.
Wan, Kangkang, Jian Shang, Guannan Zhang, et al.. (2021). Evaluating the Clinical Performance of a Dual-Target Stool DNA Test for Colorectal Cancer Detection. Journal of Molecular Diagnostics. 24(2). 131–143. 11 indexed citations
14.
Liu, Yutong, et al.. (2019). The establishment of CMV antigen-specific enzyme-linked immunospot assay among Chinese: A pilot study. Clinica Chimica Acta. 500. 143–148. 1 indexed citations
15.
Dou, Yaling, et al.. (2018). HLA-B*58:01 and rs9263726 have a linkage, but not absolute linkage disequilibrium in Han Chinese population. Drug Metabolism and Pharmacokinetics. 33(5). 228–231. 4 indexed citations
16.
Li, Dandan, Jie Wu, Jie Yi, et al.. (2018). Methylation of NBPF1 as a novel marker for the detection of plasma cell-free DNA of breast cancer patients. Clinica Chimica Acta. 484. 81–86. 14 indexed citations
17.
Zhang, Chao, Xiaonan Liu, Yao Yao, et al.. (2018). Genotyping of Multiple Clinical Samples with a Combined Direct PCR and Magnetic Lateral Flow Assay. iScience. 7. 170–179. 10 indexed citations
18.
Yue, Ting, Xiaodong Zheng, Yaling Dou, et al.. (2016). Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy. BMC Cancer. 16(1). 665–665. 27 indexed citations
19.
Dou, Yaling, Hanzhong Li, Zhicai Zhang, et al.. (2015). Improved sensitivity and specificity for prostate cancer diagnosis based on the urine PCA3/PSA ratio acquired by sequence-specific RNA capture. Oncology Reports. 34(5). 2439–2444. 13 indexed citations
20.
Ni, Anping, Lingjun Kong, Wenjuan Yan, et al.. (2012). [Analysis of cytomegaloviral antigenemia test and re-test after antiviral chemotherapy in patients with autoimmune and non-autoimmune diseases].. PubMed. 92(34). 2426–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026